Published: 1 July 2025
Updated: 8 August 2025
Nebraska’s medical marijuana program is moving forward, but its rollout is proving more complicated than lawmakers anticipated. The Nebraska Medical Cannabis Commission - created by two voter-approved 2024 ballot measures - is racing to meet a statutory October 1 deadline to issue licenses, all while operating without dedicated funding, full-time staff, or authority to collect licensing fees.
The program’s framework was established by emergency regulations signed by Governor Jim Pillen on June 29 and reaffirmed in late July. These temporary rules, in effect until September 28, were enacted to meet ballot initiative requirements for license applications to be accepted by July 1 and awarded no later than October 1.
Under the rules, Nebraska will have one of the most restrictive medical cannabis markets in the country:
While patients may legally possess inhaled or flavored products if obtained elsewhere, Nebraska-based cultivators and dispensaries cannot produce or sell them.
These restrictions sparked heated debate at the commission’s August meeting.
Commissioners defended the bans, citing public health concerns, the absence of FDA approval for smoked medicines, and forthcoming research by Commissioner Monica Oldenburg pointing to potential harms from smoking and flavor additives, particularly for youth exposure.
Other eligibility and operational rules for the industry remain strict:
Consumer protections include tight packaging, labeling, and inventory tracking requirements. Marketing materials cannot feature imagery or branding likely to appeal to minors.
Funding remains a major obstacle. The Legislature provided no direct budget for the commission, allocating just $30,000 to the Nebraska Liquor Control Commission for overlapping duties. Commissioners are exploring unconventional approaches, such as having licensees pay seed-to-sale tracking providers directly - in a method untried by other states.
Applications for cultivation, manufacturing, transportation, and dispensary licenses are being accepted by email, though the official application form is still in development. The commission may phase in approvals, starting with cultivators, to stay on track for the October deadline.
The next commission meeting is scheduled for September 2, when updated draft rules are expected. Whether Nebraska can balance public health priorities, patient needs, and the realities of building a regulatory system from scratch remains an open question.